11 May 2016
What do you get from your subscription?
10 year forecasts
View Datamonitor Healthcare’s 10-year patient based forecasts for key respiratory diseases, including insight into the future impact of elusive inhaled generics
Insight into asthma and other key respiratory diseases, looking at prescribing influences based on results from surveys of pulmonologists in the US, Japan, and five major EU markets
Examine patient populations, 10 year incident case forecasts and patient segments to recognize market potential
Pipeline and marketed drugs
View marketed and pipeline analysis, covering all phases of development and understand how novel drug classes stack up to current blockbusters in the respiratory market